Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma

PURPOSE: Systemic inflammatory biomarkers can improve diagnosis and assessment of chronic obstructive pulmonary disease (COPD) and asthma. We aimed to validate an airway disease biomarker panel of 4 systemic inflammatory biomarkers, α2-macroglobulin, ceruloplasmin, haptoglobin and hemopexin, to esta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy Asthma Immunol Res
Main Authors: Winter, Natasha A., Gibson, Peter G., Fricker, Michael, Simpson, Jodie L., Wark, Peter A., McDonald, Vanessa M.
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984952/
https://ncbi.nlm.nih.gov/pubmed/33733639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2021.13.3.450
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados